Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 80 (5) , 527-535
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation
This publication has 45 references indexed in Scilit:
- Dynamic Population Changes in Mycobacterium tuberculosis During Acquisition and Fixation of Drug Resistance in PatientsThe Journal of Infectious Diseases, 2012
- New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring StructureAntimicrobial Agents and Chemotherapy, 2012
- Rates and Mechanisms of Resistance Development inMycobacterium tuberculosisto a Novel Diarylquinoline ATP Synthase InhibitorAntimicrobial Agents and Chemotherapy, 2010
- Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5–MmpL5 efflux systemTuberculosis, 2009
- Diarylquinolines target subunit c of mycobacterial ATP synthaseNature Chemical Biology, 2007
- A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910Proteins: Structure, Function, and Bioinformatics, 2007
- Multicenter Laboratory Validation of the BACTEC MGIT 960 Technique for Testing Susceptibilities of Mycobacterium tuberculosis to Classical Second-Line Drugs and Newer AntimicrobialsJournal of Clinical Microbiology, 2006
- Drug Resistance Evolution of a Mycobacterium tuberculosis Strain from a Noncompliant PatientJournal of Clinical Microbiology, 2005
- A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosisScience, 2005
- Encoded errors: mutations and rearrangements mediated by misalignment at repetitive DNA sequencesMolecular Microbiology, 2004